NOTCH2 and autoimmune disease: These findings suggest that CD4+Notch2+Foxp3lo T cells may serve as novel mediators of the transition from the dysfunctional phenotype to immune regulatory conditions through Notch2 expression, potentially representing a new therapeutic target for autoimmune diseases.